Clinical Trial Update: Safety Study to Evaluate Induction and Consolidation Treatment in Patients With Mantle Cell Lymphoma (LCM-04-02) [Phase 2]

View source ↗

Summary

This Phase 2 safety study evaluating induction and consolidation therapy for mantle cell lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Snippet

Sponsor: CABYC | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: COMPLETED